Prevalence of BK virus in transplant patients at the Hospital de Clínicas, FCM- UNA de Clínicas, FCM-UNA

Authors

  • Rossana Mabel Vera Duarte Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Hospital de Clínicas, Departamento de Nefrología Adultos, San Lorenzo, Paraguay. Sociedad Paraguaya de Trasplantes, Asunción, Paraguay. https://orcid.org/0009-0005-6153-4174
  • Idalina Stanley Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Hospital de Clínicas, Departamento de Nefrología Adultos, San Lorenzo, Paraguay. Sociedad Paraguaya de Trasplantes, Asunción, Paraguay. https://orcid.org/0000-0003-4928-3585
  • Eladio José Aquino Becker Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Hospital de Clínicas, Departamento de Nefrología Adultos, San Lorenzo, Paraguay. https://orcid.org/0000-0003-2735-9825
  • Fernanda Prieto Sociedad Paraguaya de Trasplantes. Asunción, Paraguay. https://orcid.org/0000-0002-6350-3241
  • Héctor Fernando Da Ponte González Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Hospital de Clínicas, Departamento de Nefrología Adultos, San Lorenzo, Paraguay. Sociedad Paraguaya de Trasplantes, Asunción, Paraguay. https://orcid.org/0000-0001-7676-4144

DOI:

https://doi.org/10.70108/nefrologiapy.2024.2.1.22

Keywords:

BK polyomavirus, Kidney transplant, Immunosuppression

Abstract

Introduction: BK polyomavirus (PBK) infection is an emerging problem in kidney transplantation that contributes to the chronic loss of kidney grafts, and in which immunosuppression plays a decisive role in its appearance.

Objective: To determine the prevalence of BK virus in transplant patients from the Hospital de Clínicas, FCM-UNA. Period August 2019 to May 2022.

Materials and methods: Observational, descriptive, prospective, cross-sectional study. Twenty-seven patients who underwent kidney transplantation were included, and BKV dosage was requested.

Results: 27 patients with VBK dosage were included, of which 11.11% (3) had positive isolation in plasma or urine. The average age of the patients with positive isolate was 39±3 years, with a maximum age of 52 and a minimum of 22 years. O

them (66.6%) were female, 100% from the Central department. The average time between the transplant and the primary infection in blood or urine was 39+/- 13 months, with a range of 4-31 months, of which 66.6% occurred within 4 months. Regarding the type of donors, (66.6%) were cadaveric donors and (33.3%) were living.

Conclusion: The prevalence of BKV in transplant patients from the Hospital de Clínicas was 11.11%, the average age of those infected was 39 years, predominantly female, from the Central Department, the average time elapsed between the trans- plant and the primary infection was 39 months. In those studied, the cadaveric donor predominated.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

(1) McCaffrey J, Bhute VJ, Shenoy M. BK virus infection and outcome following kidney transplantation in childhood. Sci Rep. 202128;11(1):2468.

(2) Park WY, Kang SS, Jin K, Park SB, Choe M, Han S. Longterm prognosis of BK virus-associated nephropathy in kidney transplant recipients. Kidney Res Clin Pract. 2018;37(2):167-173.

(3) Sanz García C.,Fraile Gómez Pilar. Nefropatía con poliomavirus BK en pacientes con trasplante renal. Nefrología 11 (01),102 -109, 2019.

(4) Burgos D., Jironda C.,Martin, M.,Gonzalez – Molina,M., y Hernandez, D..(2010)Nefropatia asociada a infeccion por poliomavirus BK. Nefrologia(Madrid),30(6), 613-617.

(5) Torres Santander MB, Guañuna Ma, Garcés N. Infección por Poliomavirus en pacientes trasplantados renales del Hospital Carlos Andrade Marín, enero 2013 a diciembre 2014. Cambios Rev Med. 2017; 15 (1): 6-23.

(6) Avellán Boza M. Perfil epidemiológico de pacientes trasplantados de riñón con citología urinaria por virus BK positiva en el servicio de nefrología del Hospital Rafael Ángel Calderón Guardia en el periodo comprendido entre febrero 2013 y junio 2014 [Tesis]. Costa Rica: Universidad de Costa Rica. Sistema de Estudio de Posgrado; 2014.

(7) Diana Manzano Sánchez. Infección del virus bk en el trasplante renal. [Tesis]. Universidad de Murcia; Escuela Internacional de Doctorado. Murcia, España, 2018.

(8) Mohammad D, Kim DY, Baracco R, Kapur G, Jain A. Treatment of BK virus with a stepwise immunosuppression reduction and intravenous immunoglobulin in pediatric kidney transplant. Pediatr Transplant. 2022; 26(4):e14241.

(9) Madden K, Janitell C, Sower D, Yang S. Prediction of BK viremia by urine viral load in renal transplant patients: An analysis of BK viral load results in paired urine and plasma samples. Transpl Infect Dis. 2018;20(5):e12952.

(10) Rogers R, Bodziak K, Cheema F, Chobanian M, Ebcioglu Z, Gabardi S, et al. Implementing a regional standardized BK polyomavirus screening protocol across eleven transplant centres. Transpl Int. 2021;34(12):2680-2685.

(11) irsch HH, Vincenti F, Friman S, Tuncer M, Citterio F, Wiecek A, et al. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant. 2013; 13:136-45.

(12) Barreto P, Almeida M, Dias L. BK virus nephropathy in kidney transplantation: a literature review. Port J Nephrol Hy- pert. 2016; 30 (4): 259-268.

Published

2024-06-25

How to Cite

1.
Vera Duarte RM, Stanley I, Aquino Becker EJ, Prieto F, Da Ponte González HF. Prevalence of BK virus in transplant patients at the Hospital de Clínicas, FCM- UNA de Clínicas, FCM-UNA. Rev. Soc. Parag. Nefrol. [Internet]. 2024 Jun. 25 [cited 2024 Nov. 21];2(1):22-5. Available from: https://revista.spn.org.py/index.php/rspn/article/view/16

Issue

Section

Original Articles